123 related articles for article (PubMed ID: 34331022)
1. Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
Niederwieser C; Morozova E; Zubarovskaya L; Zabelina T; Klyuchnikov E; Janson D; Wolschke C; Christopeit M; Ayuk F; Moiseev I; Afanasyev BV; Kröger N
Bone Marrow Transplant; 2021 Nov; 56(11):2834-2841. PubMed ID: 34331022
[TBL] [Abstract][Full Text] [Related]
2. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
3. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.
Ma YR; Huang XJ; Xu ZL; Liu KY; Chen H; Zhang XH; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Chen Y; Yan CH; Xu LP
Clin Transplant; 2016 Sep; 30(9):994-1001. PubMed ID: 27292967
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.
Radujkovic A; Dietrich S; Blok HJ; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sorà F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socié G; Maertens J; Schaap N; Stadler M; Itälä-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kröger N; Chalandon Y
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2008-2016. PubMed ID: 31271884
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis.
Wang Y; Wu D; Sun A; Jin Z; Qiu H; Miao M; Tang X; Fu Z
Int J Hematol; 2008 Mar; 87(2):167-171. PubMed ID: 18288566
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Boehm A; Walcherberger B; Sperr WR; Wöhrer S; Dieckmann K; Rosenmayr A; Pernicka E; Fischer G; Worel N; Mitterbauer G; Schwarzinger I; Mitterbauer M; Haas OA; Lechner K; Hinterberger W; Valent P; Greinix HT; Rabitsch W; Kalhs P
Biol Blood Marrow Transplant; 2011 Jan; 17(1):133-40. PubMed ID: 20601032
[TBL] [Abstract][Full Text] [Related]
9. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
[TBL] [Abstract][Full Text] [Related]
10. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.
Xu LP; Xu ZL; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang JZ; Wang Y; Yan CH; Mo XD; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1080-1086. PubMed ID: 26995693
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Kebriaei P; Detry MA; Giralt S; Carrasco-Yalan A; Anagnostopoulos A; Couriel D; Khouri IF; Anderlini P; Hosing C; Alousi A; Champlin RE; de Lima M
Blood; 2007 Nov; 110(9):3456-62. PubMed ID: 17652620
[TBL] [Abstract][Full Text] [Related]
13. Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.
Xu L; Zhu H; Hu J; Wu D; Jiang H; Jiang Q; Huang X
Front Med; 2015 Sep; 9(3):304-11. PubMed ID: 26100855
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of allogeneic hematopoietic stem cell transplantation in treatment of childhood myelogenous leukemia: the observation of 24 cases].
Sun Y; Sun RJ; Wei ZJ; Xiao J; Zhang YC; Gao YQ; Zhu HL
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):813-6. PubMed ID: 23302609
[TBL] [Abstract][Full Text] [Related]
15. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
De Souza CA; Vigorito AC; Ruiz MA; Nucci M; Dulley FL; Funcke V; Tabak D; Azevedo AM; Byington R; Macedo MC; Saboya R; Penteado Aranha FJ; Oliveira GB; Zulli R; Martins Miranda EC; Azevedo WM; Lodi FM; Voltarelli JC; Simões BP; Colturato V; De Souza MP; Silla L; Bittencourt H; Piron-Ruiz L; Maiolino A; Gratwohl A; Pasquini R
Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
[TBL] [Abstract][Full Text] [Related]
16. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
Huang XJ; Xu LP; Liu KY; Liu DH; Chen H; Liu YR; Chen YH; Han W; Wang Y
Biol Blood Marrow Transplant; 2011 May; 17(5):649-56. PubMed ID: 20691800
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.
Suttorp M; Claviez A; Bader P; Peters C; Gadner H; Ebell W; Dilloo D; Kremens B; Kabisch H; Führer M; Zintl F; Göbel U; Klingebiel T
Klin Padiatr; 2009; 221(6):351-7. PubMed ID: 19890786
[TBL] [Abstract][Full Text] [Related]
20. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
